General Information of Binding Target of SBP (BTS) (ID: ST00270)
BTS Name
Disintegrin and metalloproteinase domain-containing protein 17
Synonyms
ADAM 17; EC 3.4.24.86; TNF-alpha convertase; TNF-alpha-converting enzyme; CD antigen CD156b
BTS Type
Protein
Gene Name
Adam17
Organism
Mus musculus (Mouse)
Function
Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Plays a role in the proteolytic processing of ACE2 (By similarity). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called notch extracellular truncation (NEXT) Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (By similarity).
UniProt ID
Q9Z0F8
UniProt Entry
ADA17_MOUSE
PFam
PF16698 ; PF00200 ; PF01562
Gene ID
11491
Sequence
MRRRLLILTTLVPFVLAPRPPEEAGSGSHPRLEKLDSLLSDYDILSLANIQQHSIRKRDL
QSATHLETLLTFSALKRHFKLYLTSSTERFSQNLRVVVVDGKEESEYSVKWQNFFSGHVV
GEPDSRVLAHIGDDDVTVRINTDGAEYNVEPLWRFVNDTKDKRMLVYKSEDIKDFSRLQS
PKVCGYLNADSEELLPKGLIDREPSEEFVRRVKRRAEPNPLKNTCKLLVVADHRFYKYMG
RGEESTTTNYLIELIDRVDDIYRNTSWDNAGFKGYGVQIEQIRILKSPQEVKPGERHFNM
AKSFPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANS
HGGVCPKAYYNPTVKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGL
AECAPNEDQGGKYVMYPIAVSGDHENNKMFSNCSKQSIYKTIESKAQECFQERSNKVCGN
SRVDEGEECDPGIMYLNNDTCCNSDCTLKPGVQCSDRNSPCCKNCQFETAQKKCQEAINA
TCKGVSYCTGNSSECPPPGDAEDDTVCLDLGKCKAGKCIPFCKREQELESCACVDTDNSC
KVCCRNLSGPCVPYVDAEQKNLFLRKGKPCTVGFCDMNGKCEKRVQDVIERFWDFIDQLS
INTFGKFLADNIVGSVLVFSLIFWIPFSILVHCVDKKLDKQYESLSLFHHSNIEMLSSMD
SASVRIIKPFPAPQTPGRLQALQPAAMMPPVPAAPKLDHQRMDTIQEDPSTDSHADDDGF
EKDPFPNSSTAAKSFEDLTDHPVTRSEKAASFKLQRQSRVDSKETEC
Sequence Length
827
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
scFv anti-HBV PreS1/TACE A9 Research Binder Kd: 90 nM Hepatitis B virus infection [ICD-11: XN0GA]
SBP Info
[1], [2]
scFv anti-TACE A9 Research Binder Kd: 90 nM Cancers [ICD-11: 2D4Z]
SBP Info
[2]
scFv anti-TACE H7 Research Inhibitor Kd: 0.05 nM Cancers [ICD-11: 2D4Z]
SBP Info
[2]
References
1 Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant library. Viral Immunol. Spring 2006;19(1):115-23.
2 Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy. Protein Eng Des Sel. 2014 Jun;27(6):179-90.